Capstone Holding Corp. (CAPS) ist ein börsennotiertes Unternehmen im Grundstoffe Sektor, tätig in der Construction Materials Branche. Der Hauptsitz des Unternehmens ist in Alsip, IL, United States. Der aktuelle CEO ist Matthew E. Lipman.
CAPS hat IPO-Datum 1993-01-28, 36 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke, eine Marktkapitalisierung von $3.18M.
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
